EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
KNOWLEDGE BANK
-
Articles
Beyond Traditional Signal Detection: Advancing Pharmacovigilance Through Quantitative Epidemiology
The emergence of increasingly targeted medicines is changing the questions that pharmacovigilance must answer Antibodydrug conjugates cellular therapies genebased treatments and other advanced modalities can provide substantial therapeutic benefit yet their safety profiles may reflect complex biological mechanisms heterogeneous patient populations and delayed effects Detecting a numerical imbalanc...
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
Single-cell transcriptomics and machine learning characterize LTA4H-linked lipid metabolism and inflammatory signatures in the knee osteoarthritis IPFP/synovium compartment
Knee osteoarthritis KOA is a wholejoint disease characterized by inflammation immune dysregulation and metabolic imbalance
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Biomarkers in Focus: Enhancing Clinical Research and Patient Care
Kate Williamson
Biomarkers are vital in clinical research and patient care, enabling early diagnosis, personalized treatments, and disease monitoring. This article explores their types, roles in drug development, and...
-
2
Ensuring Patient Safety: The Essentials of Drug Safety & Pharmacovigilance
Kate Williamson
This article explores the critical role of drug safety and pharmacovigilance in ensuring patient safety, covering processes from preclinical studies to post-market surveillance, challenges like underr...
-
3
The Future of Pharma Partnerships: Strategic Alliances Driving Innovation
Lakshmi
Partnerships have moved from the margins of pharmaceutical strategy to its center, yet most alliances still underdeliver against the case that justified them. This article examines how deal architectu...
-
4
Quality in Pharmaceutical Manufacturing
Venkata Reddy Pothireddy
Quality is fundamental to pharmaceutical manufacturing, ensuring product safety, efficacy, consistency, and regulatory compliance. This review discusses pharmaceutical quality principles, Quality Mana...
-
5
Patient-Centric Approaches in Clinical Trials
Vasudev Bhupathi
Patient-centric clinical trials embed participants’ needs at every stage, co-designed protocols, decentralized visits, digital health tools, diversity metrics, and transparent results. This para...
press releasesRead more...
Stipple Bio Announces Multi-Target Multi-Modality Oncology Research Collaboration with Lilly
Stipple Bio Inc a private biotechnology company harnessing epitopelevel precision to create targeted cancer therapies today announced that it has entered into a multitarget multimodality strategic research collaboration and license agreement with Eli Lilly and Company
Cardiff Oncology Receives FDA Fast Track Designation for Onvansertib in First-Line RAS-Mutated Metastatic Colorectal Cancer
Cardiff Oncology Inc Nasdaq CRDF a clinicalstage biotechnology company targeting RASmutated cancer by leveraging PLK inhibition today announced that the US Food and Drug Administration FDA has granted Fast Track designation to onvansertib in combination
Sino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery
AIdriven protein design is accelerating the discovery of novel protein binders but experimental validation remains essential to determine whether computational designs translate into meaningful target interactions To bridge this gap Sino Biological Inc Shenzhen Stock Exchange SZ a global leader in r...
Kamau Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Nula-cel, a Gene-Corrected Stem Cell Therapy for Sickle Cell Disease
Kamau Therapeutics a clinicalstage company creating medicines that endure by precisely engineering patients own blood stem cells today announced that the US Food and Drug Administration FDA has granted Regenerative Medicine
Events Read more...
16 - 17
Nov 2026Analytics for Smarter Decisions in Pharma
London, UK
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
24 - 25
Nov 2026BioPharma Deals Conference 2026
Science Congress Center, Munic...
26 - 28
Nov 2026One Health Conference 2026
Thapar Institute of Engineerin...
01 - 03
Dec 2026Pharmaceutical Launch Excellence Summit
Novotel Amsterdam City, Nether...
01 - 03
Dec 202610th Antifibrotic Drug Development
Boston, MA at the Hotel Common...
02 - 04
Dec 2026Genome Informatics 2026
Wellcome Genome Campus, UK
03 - 04
Dec 2026Pharmacy and Pharmaceutical Conference
Madrid, Spain
LATEST NEWSRead more...
Novartis’ Cosentyx becomes first anti-IL-17 biologic approved for polymyalgia rheumatica
Novartis has received approval from the US Food and Drug Administration FDA for Cosentyx secukinumab mg to treat adults with polymyalgia rheumatica PMR who have not responded adequately to corticosteroids or cannot tolerate a reduction in their corticosteroid dose
Roche’s Gazyva/Gazyvaro becomes first FDA-approved treatment for primary membranous nephropathy
Roche has received approval from the US Food and Drug Administration FDA for GazyvaGazyvaro obinutuzumab to treat adults with primary membranous nephropathy pMN who are at risk of disease progression
Cyclarity Therapeutics Receives FDA Clearance for UDP-003 Clinical Trial Application in the US
Cyclarity Therapeutics Inc has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for UDP enabling the company to expand its atherosclerosis clinical development programme into the United States
Santhera Signs Distribution Agreement with SteinCares for AGAMREE in 31 Latin American and Caribbean Countries
Cyclarity Therapeutics Inc has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for UDP enabling the company to expand its atherosclerosis clinical development programme into the United States
Oncolytics Biotech Signs Clinical Supply Agreement to Evaluate Pelareorep with LOQTORZI in Anal Cancer
Oncolytics Biotech Inc Nasdaq ONCY a clinicalstage immunotherapy company developing pelareorep has signed a clinical supply agreement with Coherus Oncology to evaluate pelareorep in combination with LOQTORZI toripalimabtpzi in patients with squamous cell anal carcinoma SCAC
MD Logic Health and Blu Vitals Launch Nine-Form Magnesium Supplement Mag 9+
MD Logic Health has partnered with Blu Vitals to launch Mag the first product developed through their collaboration The new magnesium supplement combines nine forms of magnesium with four additional nutrients in a daily formula designed to support energy production muscle and nerve function and bon...



